A Safety and Efficacy Study of OnabotulinumtoxinA in Forehead and Glabellar Facial Rhytides

Clinical trial NCT02261467 · COMPLETED

Trial details

NCT number: NCT02261467
Sponsor: Allergan
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Forehead Rhytides Glabellar Rhytides

Start date: 2014-10-21
Primary completion: 2015-06-04
Enrollment: 421

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.